マーケットレポート詳細

エクソソーム(Exosome)診断および治療：世界市場2026年予測

Exosome Diagnostics and Therapeutics: Global Markets

出版元：BCC Research　 出版元について
発行年：2021年11月
定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文255ページになります。
商品コード：BCC335

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

エクソソーム診断および治療の世界市場規模は2021年に推計9,780万ドル、2026年には5億1,260万ドルへと急拡大が見込まれます。当レポートでは、エクソソーム診断および治療の市場/技術的背景、COVID-19によるエクソソーム治療市場への影響、エクソソーム診断市場、エクソソーム治療市場、エクソソーム試薬および研究ツール市場、各種セグメント別市場分析(エンドユーザー別、地域別)、特定のバイオ医薬品市場に対するエクソソーム研究の影響、特許/パイプライン分析、市場サマリー、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術的背景

・エクソソームの定義と命名法
・エクソソームの発見
・エクソソームコンポーネント
・エクソソームの分離と検出
・エクソソーム研究および製品開発のためのバイオインフォマティックデータベース
・エクソソームの機能と生理学

◆COVID-19によるエクソソーム治療市場への影響

・概要
・エクソソームとCOVID-19治療

◆エクソソーム診断市場

・診断バイオマーカーとしてのエクソソームタンパク質
・診断バイオマーカーとしてのエクソソーム核酸
・エクソソームベースの診断製品開発の潜在市場としての癌診断
・エクソソームセクターにおける診断の可能性としてのリキッドバイオプシー
・アッセイ開発における癌バイオマーカーとしてのエクソソームタンパク質と核酸
・エクソソーム診断製品開発の潜在市場
-中枢神経系障害と神経変性疾患
-感染症
-心血管疾患
-出生前診断
-臓器移植

・エクソソームベースの診断セクターの市場参加者
・エクソソーム市場における現在の診断セクターの評価
※市場予測データ-2026年掲載

◆エクソソーム治療市場

・エクソソーム固有の治療活性
・免疫学的適合性
・貨物機能
・エクソソームを介した治療薬の生成
・エクソソームを特定のレシピエント細胞にターゲティングする
・合成ベクターとしてのエクソソームの設計
・エクソソーム治療薬の市場可能性
・エクソソームベースの治療セクターの市場参加者
・エクソソーム市場における現在の治療セクターの評価
※市場予測データ-2026年掲載

◆エクソソーム試薬および研究ツール市場

・市場概要
・エクソソーム研究のための試薬とツールの市場参加者
・エクソソーム市場における現在のツールと試薬の評価
※市場予測データ-2026年掲載

◆エクソソーム診断および治療市場、エンドユーザー別

・がん研究所
・病院および診断センター
・その他：製薬/ライフサイエンス産業/学術機関
※市場予測データ-2026年掲載

◆エクソソーム診断および治療市場、地域別

・北米
・欧州
・アジア太平洋
・その他地域
※市場予測データ-2026年掲載

◆特定のバイオ医薬品市場に対するエクソソーム研究の影響

・バイオマーカーと診断業界
・マイクロRNA市場
・リキッドバイオプシー市場
・幹細胞テクノロジー市場
・出生前診断市場
・農業および食品産業
・マイクロフルイディクスとナノテクノロジー
・スキンケア業界

◆特許/パイプライン分析

・米国の特許分析
・欧州の特許分析
・日本の特許分析
・パイプライン分析

◆市場サマリー

◆主要企業プロフィール

・CODIAK BIOSCIENCES
・EVOX THERAPEUTICS LTD.
・EXOSOME DIAGNOSTICS INC.
・HANSABIOMED LIFE SCIENCES LTD. (LONZA)
・NANOSOMIX INC.
・SYSTEM BIOSCIENCES (SBI)

(全255頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
What's New in This Report?
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Exosome Definition and Nomenclature
Discovery of Exosomes

Exosome Components

Isolation and Detection of Exosomes

Bioinformatic Databases for Exosome Research and Product Development

Exosome Function and Physiology

Chapter 4 Impact of COVID-19 on the Exosome Therapeutics Market

Overview

Exosome and COVID-19 Treatment

Chapter 5 Exosome Diagnostics Market

Exosomal Proteins as Diagnostic Biomarkers
Exosomal Nucleic Acids as Diagnostic Biomarkers
Cancer Diagnostics as Market Potential for Exosome-Based Diagnostic Product Development

Liquid Biopsy as Potential for Diagnostics in the Exome Sector
Exosomal Proteins and Nucleic Acids as Cancer Biomarkers in Assay Development
CNS Disorders and Neurodegeneration Diseases as Market Potential for Exosome Diagnostics Product Development
Infectious Diseases as Market Potential for Exosome Diagnostic Product Development
Cardiovascular Diseases as Market Potential for Exosome Diagnostic Product Development
Prenatal Testing as Market Potential for Exosome Diagnostic Product Development
Organ Transplantation as Market Potential for Exosome Diagnostic Product Development
Market Participants in the Exosome-Based Diagnostics Sector

Evaluation of the Current Diagnostics Sector in the Exosome Market

Chapter 6 Exosome Therapeutics Market

Intrinsic Therapeutic Activity of Exosomes
Immunological Compatibility
Cargo Capabilities
Generation of Exosome-Mediated Therapeutics

Targeting Exosomes to Specific Recipient Cells
Designing Exosomes as a Synthetic Vector
Market Potential for Exosome Therapeutics
Market Participants in the Exosome-Based Therapeutics Sector

Evaluation of the Current Therapeutics Sector in the Exosome Market

Chapter 7 Exosome Reagents and Research Tools Market

Market Overview

Market Participants in Reagents and Tools for Exosome Research

Evaluation of Current Tools and Reagents in the Exosome Market

Chapter 8 Global Exosome Therapeutic and Diagnostics Market by End User

Cancer Institutes
Hospital and Diagnostic Centers

Others: Pharmaceutical and Life Science Industries and Academic Institutes

Chapter 9 Global Exosome Therapeutic and Diagnostics Market by Region

North America
Europe
Asia-Pacific
Rest of the World

Chapter 10 Impact of Exosome Research on Specific Biopharmaceutical Markets

Biomarker and Diagnostic Industry
MicroRNA Market
Liquid Biopsy Market
Stem Cell Technologies Market
Prenatal Diagnostic Market
Agriculture and Food Industry
Microfluidics and Nanotechnology
Skincare Industry

Chapter 11 Patents and Pipeline Analysis

U.S. Patent Analysis
European Patent Analysis
Japanese Patent Analysis
Pipeline Analysis

Chapter 12 Market Summary

Chapter 13 Company Profiles

CODIAK BIOSCIENCES
EVOX THERAPEUTICS LTD.
EXOSOME DIAGNOSTICS INC.
HANSABIOMED LIFE SCIENCES LTD. (LONZA)
NANOSOMIX INC.
SYSTEM BIOSCIENCES (SBI)

List of Tables

Summary Table : Global Market for Exosome Diagnostics and Therapeutics, by Application, Through 2026
Table 1 : Nomenclature of Exosome Particles
Table 2 : Publication Trend about Exosome, 2010-2020
Table 3 : Molecules Involved in Exosome Biogenesis and/or Release
Table 4 : Steps in Exosome Biogenesis and Processing
Table 5 : Proteins Essential in Exosome Biogenesis and Processing
Table 6 : Proteins Found in Exosomes
Table 7 : MicroRNA in Different Bodily Fluids, by Sample
Table 8 : Methods for Exosome Isolation
Table 9 : Distribution of Exosomes Isolation Procedures in the Studies Cataloged in ExoCarta
Table 10 : Data Cataloged in ExoCarta, 2012 and 2017
Table 11 : Data Cataloged in Vesiclepedia, 2012, 2017 and 2020
Table 12 : Data Cataloged in EVpedia, 2018
Table 13 : Comparison of Databases for Exosome Studies
Table 14 : Coronavirus Reported Cases and Deaths, by Country, as of May 2021
Table 15 : Examples of Exosomal Proteins for Clinical Diagnostic Applications
Table 16 : Examples of Exosomal MicroRNA for Clinical Diagnostic Applications
Table 17 : Characteristic Exosomal MicroRNAs in Various Biological Fluids
Table 18 : Expression Status of MicroRNAs as the Exosomal Cargo in Different Cancer Types
Table 19 : Exosomal Protein Biomarkers for Diagnosis of Different Cancers
Table 20 : Exosomal Nucleic Acid Biomarkers for Diagnosis of Different Cancers
Table 21 : Statistics for Prostate Cancer, 2021
Table 22 : Studies of microRNAs in PCa Patients
Table 23 : Global Market for Prostate Cancer Diagnostics and Related Cost, 2017 and 2022
Table 24 : Statistics for Breast Cancer, 2021
Table 25 : Global Market for Breast Cancer Diagnostics, Through 2024
Table 26 : U.S. Statistics for Bladder Cancer, 2021
Table 27 : Functions of Exosomal Noncoding RNAs and Proteins in Tumor Metastasis and Invasion
Table 28 : Global Market for Bladder Cancer Diagnostics, 2017
Table 29 : Statistics for Ovarian Cancer, 2021
Table 30 : MicroRNA Content of Ovarian Cancer-Derived Exosomes
Table 31 : Global Market for Ovarian Cancer Diagnostics, Through 2022
Table 32 : Summary of the Predictive Exosomal Components Described Until Now, Including Utility and Values Represented, by Sensitivity
Table 33 : Statistics for Lung Cancer, 2021
Table 34 : Global Market for Lung Cancer Diagnostics, 2019
Table 35 : Differences between Liquid and Tissue Biopsy for Cancer Detection and Evaluation
Table 36 : Global Market for Liquid Biopsy including Research Tools, Services and Diagnostics, Through 2025
Table 37 : Exosomal Protein Biomarkers from Bodily Fluids of Patients in Pre-Clinical and Clinical Studies
Table 38 : Exosomal Nucleic Acid Biomarkers in Pre-Clinical and Clinical Studies
Table 39 : U.S. Statistics for Alzheimer’s Disease, 2021
Table 40 : Global Market for Alzheimer’s Disease Therapeutics and Diagnostics, Through 2025
Table 41 : Global Statistics for Hepatitis C Infection, 2020
Table 42 : Estimated Actual New Cases of HAV (Range), 2016 and 2019
Table 43 : Global Market for Hepatitis C Diagnostics, 2017
Table 44 : U.S. Statistics for Cardiovascular Diseases, 2020
Table 45 : Global Market for Cardiovascular Diagnostics, 2020
Table 46 : Global Market for Prenatal Diagnostics, Predictive Tests and Neonatal Monitoring, Through 2023
Table 47 : Global Market for Organ and Tissue Transplantation Products and Devices, Through 2024
Table 48 : Comparison of Exosome Diagnostics’ Approach to Other Liquid Biopsy Platforms
Table 49 : Main Market Participants in Exosome-Based Diagnostics Sector
Table 50 : Global Market for Exosome Diagnostics, Through 2026
Table 51 : Examples of Studies Using Extracellular Vesicles as Drug Delivery Vehicles
Table 52 : Examples of Engineering Exosome for Cargo Delivery
Table 53 : Type of Cargo and Loading Method
Table 54 : Examples of Physiological Effect of Exosome Delivery
Table 55 : Global Rankings of Top 10 Vaccine Manufacturers, 2020
Table 56 : Global Elderly Population with Alzheimer’s Dementia, by Age Group, 2021
Table 57 : Global Prevalence of Tuberculosis, 2015-2019
Table 58 : Global Prevalence of Cancer, 2010-2017
Table 59 : U.S. Statistics for Burn Injuries
Table 60 : U.S. Statistics for Pressure Ulcers
Table 61 : Global Market for Aethlon Medical, 2016-2021
Table 62 : Global Market Revenue, Cost and Profits for Capricor Therapeutics, 2016-2020
Table 63 : Main Market Participants in Exosome-based Therapeutics Sector
Table 64 : Examples of Financing for Exosome-based Therapeutics, by Company, Through 2017
Table 65 : Global Market for Exosome Therapeutics, Through 2026
Table 66 : Main Steps in Exosome Research Approach
Table 67 : Examples of Commercial Kits and Reagents for Exosome Isolation
Table 68 : Frequency of Use for Each Isolation Technique for Exosome Purification
Table 69 : Range of Model Options with Zetasizer Nano ZS Instrument
Table 70 : Examples of Detection Assay
Table 71 : Examples of Antibody Providers for Exosome Research
Table 72 : Commercial RNA Extraction Kits
Table 73 : Use of Characterization Techniques for Exosome Samples
Table 74 : Examples of Purified Exosomes Commercial Products
Table 75 : Main Market Participants in Exosome Research Tools and Reagents
Table 76 : Global Market for Exosome Research Tools and Reagents, Through 2026
Table 77 : Global Market for Exosome Therapeutics and Diagnostics, by End User, Through 2026
Table 78 : Global Market for Exosomes in Cancer Institutes, by Region, Through 2026
Table 79 : Studies Employing Exosomes without Genetic Modification in Cancer Treatment
Table 80 : In Vivo and In Vitro Studies Using Modified Exosomes for Cancer Therapy
Table 81 : List of Exosomal Bioactive Molecules Involved in Various Progressions
Table 82 : Global Market for Exosomes in Hospitals and Diagnostics Centers, by Region, Through 2026
Table 83 : Exosome Proteins in Clinical Diagnostics Applications
Table 84 : Exosomes: Novel Biomarkers for Clinical Diagnosis
Table 85 : Global Market for Exosomes in the Others End User Segment, by Region, Through 2026
Table 86 : Global Market for Exosome Diagnostics and Therapeutics, by Region, Through 2026
Table 87 : Leading Cause of Deaths Related to Cancer in the UAE, by Cancer Type, 2018
Table 88 : Leading Causes of Death in Argentina, and Percent Change, 2005-2016
Table 89 : Examples of Protein Markers in Exosomes and Their Related Pathologies
Table 90 : Examples of MicroRNA Markers in Exosomes and Their Related Pathologies
Table 91 : Comparison Between Liquid Biopsy and Tissue Biopsy
Table 92 : Major Companies Researching and Producing Exosome Products
Table 93 : U.S. Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 94 : European Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 95 : Japanese Patents on Exosome Diagnostics and Therapeutics, Jan. 2016–Sept. 2021
Table 96 : Clinical Trials on Various Exosome Molecules
Table 97 : Global Market for Exosome Diagnostics and Therapeutics, by Application, Through 2026
Table 98 : Main Participants in the Exosome Market
Table 99 : Product Portfolio: Codiak Biosciences
Table 100 : Recent Development: Codiak Biosciences
Table 101 : Product Portfolio: Evox Therapeutics Ltd.
Table 102 : Recent Development: Evox Therapeutics Ltd.
Table 103 : Product Portfolio: Exosome Diagnostics Inc.
Table 104 : Recent Developments: Exosome Diagnostics Inc.
Table 105 : Product Portfolio: HansaBioMed Life Sciences Ltd. (Lonza)
Table 106 : Recent Developments: HansaBioMed Life Sciences Ltd. (Lonza)
Table 107 : Product Portfolio: Nanosomix Inc.
Table 108 : Product Portfolio: System Biosciences (SBI)

List of Figures

Summary Figure : Global Market for Exosome Diagnostics and Therapeutics, by Application, 2019-2026
Figure 1 : Publication Trends for Exosomes, 2010-2020
Figure 2 : Differential Centrifugation Process
Figure 3 : Ciliated Porous Device Designed to Isolate Exosomes, by Filtration
Figure 4 : Sieving Models for Exosome Filtration
Figure 5 : Workflow of MiRNA-Based Therapeutic Delivery Using Exosomes to Treat Alcoholic Liver Disease
Figure 6 : Global Market for Exosome Diagnostics, 2019-2026
Figure 7 : Global Prevalence of Cancer, 2010-2017
Figure 8 : Global Market for Exosome Therapeutics, 2019-2026
Figure 9 : Global Market for Exosome Research Tools and Reagents, 2019-2026
Figure 10 : Global Cancer Prevalence, 2005-2016
Figure 11 : Global Incidence of Patients with Chronic Diseases, 2005-2030
Figure 12 : U.S. Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 13 : European Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 14 : Japanese Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 15 : Shares of Clinical Trials on Exosomes, by Phase, 2021
Figure 16 : Global Market for Exosome Diagnostics and Therapeutics, by Application, 2019-2026


△ 一番上に戻る